维普中文期刊产品整合服务
27篇 您的检索式:作者名="Poplin E"
    题名 作者 年代 出处 被引量
1Phase Ⅲ,randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (SO-minute infusion) in patients with pancreatic carcinoma E6201:a trial of the Eastern Cooperative Oncology Group显示文摘Poplin E Feng Y Berlin J 2009J Clin Oncol2009,27,23:1
2A framework for variation discovery and genotyping using next-generation DNA sequencing data显示文摘DePristo MA Banks E Poplin R 2011Nat Genet2011,43,5:1
3Phase Ⅲ trial of gemcit- abine ( 30-minute infusion) versus gemcitabine ( fixed-dose-rate in- fusion (FDR) ) versus gemcitabine + oxaliplatin (GEMOX) in pa- tients with advanced pancreatic cancer显示文摘Poplin E Levy DE Berlin J 2006J Clin Oncol2006,24,:1
4A framework for variation dis- covery and genotyping using next-generation DNA sequencing data 显示文摘DePristo M A Banks E Poplin R 2011Nature genetics2011,43,5:1
5A framework for variation discovery and genotyping using next-generation DNA sequencing data 显示文摘DePristo MA Banks E Poplin R 2011Nat Genet2011,43,5:1
6'Spontaneous'delayed colon and rectal anastomotic complications associated with bevacizumab therapy显示文摘August DA Serrano D Poplin E 0,,:1
7Determinantal identities over commutative semirings显示文摘Poplin P L Hartwig R E 0,,:1
8Safety and efficacy of EPO906 in patients with advanced colorectal cancer: a re- view of 2 phase II trials 显示文摘Poplin E Moore M O'Dwyer P 2003Pro Am Soc Clin Oncol2003,,:1
9'Spontaneous,' delayed colon and rectal anastomotic complications associated with bevacizumah therapy显示文摘August DA Serrano D Poplin E 2008J Surg Oncol2008,97,2:1
10Randomized study of gemcit- abine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group 显示文摘Poplin E Feng Y Berlin J 2009J Cliu Oncol2009,27,23:1
11Phase Ⅲ trial of gemcitabine( 30-minute infusion ) versus gemcitabine ( fixed-dose-rate intusion ) versus gemcitabinc + oxallplatin ( GEMOX ) in patients with advanced pancreatic cancer (E6201) 显示文摘Poplin E Levy DE Berlin J 2006Proc Am Soc Clin Oncol2006,24,:1
12A framework for variation discovery and genotyping using next-generation DNA sequencing data显示文摘DePristo MA Banks E Poplin R 2011Nat Genet2011,43,5:1
13Phase Ⅲ,randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201:a trial of the eastern cooperative oncology group显示文摘Poplin E 2009J Clin Oncol2009,27,:1
14Deforolimus trial 106: a phase 1 trial evaluating 7 regimens of oral deforolimus (AP23573,MK-8669) 显示文摘Mita MM Britten CD Poplin E et el 2008J Clin Oncol2008,26,:1
15Phase HI, randomized study ofgemcitabine and oxaliplatin versus gemcitabine ( fixed-close rate in-fusion) compared with gemcitabine ( 30-minute infusion) in pa-tients with pancreatic carcinoma E6201 ; A trial of the Easterncooperative oncology group 显示文摘Poplin E Feng Y Berlin J 2009J Clin Oncol2009,27,23:1
16A framework for variation discovery and genotyping using next-generation DNA sequencing data 显示文摘DePristo MA Banks E Poplin R 2011Nat Genet2011,43,5:1
17A framework for variation discovery and genotyping using nextgeneration DNA sequencing data显示文摘Depnsto MA Banks E Poplin R Garimella KV Maguire JR Hartl C Philippakis AA Del Angel G Rivas MA Hanna M Mckenna A Fennell TJ Kernytsky AM Sivachenko AY Cibulskis K Gabriel SB Altshuler D Daly MJ 0,,05:1
18Determinantal identities over commutative semirings显示文摘Poplin P L Hartwig R E 2004Linear Algebra and its Appl2004,,387:1
19Phase III, Randomized Study of Gemcitabine and OxaliplatinVersus Gemcitabine (fixed-dose rate infusion) Com- pared With Gemcitabine (30-minute infusion) in Pa- tients With Pancreatic Carcinoma E6201:A Trial of the Eastern Cooperative Oncology Group 显示文摘POPLIN E LEVY D E BERLIN J 2006J Clin Onco12006,27,23:1
20Phase III randomized study of gemcitabine and oxaliplatin versus gemcitabine(flxed-dose rate infusion)compared with gemeitabine(30-minute infusion)in patients with pancreatic carcinoma E6201:a trim of the eastern cooperative oncology group显示文摘Poplin E 2009J Clin Oncol2009,27,23:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费